SCHEMBL4906504

SCHEMBL4906504

CCN(c1nc2ccccc2s1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.48
ALDH1A1 P00352 4/20 0.45
ALOX15 P16050 2/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 3/20 0.44
ESR1 P03372 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
TP53 P04637 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
MEN1 O00255 2/20 0.42
HTT P42858 2/20 0.41
MAPT P10636 1/20 0.41
KAT8 Q9H7Z6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902640 0.89 MEN1 (0.46) LMNAALDH1A1ALOX15GAAKMT2A
SCHEMBL4897647 0.84 LMNA (0.41) LMNAALDH1A1ALOX15HPGDHSD17B10
SCHEMBL4906179 0.81 MEN1 (0.44) LMNAALDH1A1HPGDHSD17B10GAA
SCHEMBL4902828 0.79 LMNA (0.48) LMNAALDH1A1ALOX15HPGDHSD17B10
SCHEMBL4899819 0.77 C1R (0.51) LMNAALDH1A1ALOX15HPGDHSD17B10
SCHEMBL4904348 0.76 LMNA (0.47) LMNAALDH1A1ALOX15HPGDHSD17B10
SCHEMBL4903799 0.75 LMNA (0.59) LMNAALDH1A1ALOX15HPGDHSD17B10
SCHEMBL4905942 0.75 DYRK1A (0.41) ALDH1A1GAAKMT2ASMN1; SMN2NPC1
SCHEMBL4897956 0.74 LMNA (0.52) LMNAALDH1A1ALOX15HPGDHSD17B10
SCHEMBL4904182 0.73 LMNA (0.48) LMNAALDH1A1ALOX15HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885ALDH1A1 2664/4885ALOX15 1473/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885ALOX15 1494/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885ALOX15 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.